Pharmaron Beijing Co., Limited: Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie
Pharmaron Beijing Co., Limited: Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie Continues to build integrated capabilities platform for Cell Gene Therapy Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ("Pharmaron") announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited ("The ABL site") in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the second quarter of 2021, subject to the satisfaction of customary closing conditions. The ABL site con...
Source: finanznachrichten.de